(MedPage Today) — Clinicians face exciting new options in immunoglobulin A (IgA) nephropathy, with recent accelerated FDA approvals and positive data presented on agents targeting B-cell activating factor (BAFF) and a proliferation-inducing ligand…
Bid to clean up a rotten trail in Hyderabad’s thriving food scene
Beneath Hyderabad’s booming food economy lies a dark web of adulteration, mislabelling and unsafe practices. Of late, an unprecedented police-led...






